Cardiac Biomarkers Market Report: Trends, Insights, and Forecast for 2030

According to the study by Next Move Strategy Consulting, the global Cardiac Biomarkers Market is predicted to reach USD 28.29 billion, with a CAGR of 11.6% by 2030.

Cardiac biomarkers are protein-based substrates released into the blood stream when the heart is extremely stressed or damaged. Cardiac biomarkers can be traced and measured to diagnose Cardio Vascular Diseases (CVDs) such as Acute Coronary Syndrome (ACS), myocardial infraction, cardiac ischemia, and others.

According to the data World Health Organization, more than 17.9 million people worldwide, die of Cardiovascular diseases (CVDs), every year.

Request for a FREE Sample PDF: https://www.nextmsc.com/cardiac-biomarkers-market/request-sample